世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5750
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・遺伝子治療医薬品（GTMP）の市場動向
・企業の競争状況、市場シェア
・遺伝子治療医薬品（GTMP）の種類別市場規模と予測2016-2027（経口、注射）
・遺伝子治療医薬品（GTMP）の用途別市場規模と予測2016-2027（がん、単発性、感染症、循環器疾患、その他）
・遺伝子治療医薬品（GTMP）の北米市場規模2016-2027（アメリカ、カナダ）
・遺伝子治療医薬品（GTMP）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・遺伝子治療医薬品（GTMP）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・遺伝子治療医薬品（GTMP）の中南米市場規模2016-2027（メキシコ、ブラジル）
・遺伝子治療医薬品（GTMP）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bluebird Bio、Sangamo、Spark Therapeutics、Dimension Therapeutics、Avalanche Bio、Celladon、Vical Inc.、Advantagene）
・結論

Market Analysis and Insights: Global Gene Therapy Medicinal Products (GTMP) Market
The global Gene Therapy Medicinal Products (GTMP) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy Medicinal Products (GTMP) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy Medicinal Products (GTMP) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy Medicinal Products (GTMP) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy Medicinal Products (GTMP) market.

Global Gene Therapy Medicinal Products (GTMP) Scope and Market Size
Gene Therapy Medicinal Products (GTMP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy Medicinal Products (GTMP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy Medicinal Products (GTMP) Market Perspective (2016-2027)
2.2 Gene Therapy Medicinal Products (GTMP) Growth Trends by Regions
2.2.1 Gene Therapy Medicinal Products (GTMP) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy Medicinal Products (GTMP) Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy Medicinal Products (GTMP) Industry Dynamic
2.3.1 Gene Therapy Medicinal Products (GTMP) Market Trends
2.3.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
2.3.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
2.3.4 Gene Therapy Medicinal Products (GTMP) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue
3.1.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Medicinal Products (GTMP) Revenue
3.4 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio
3.4.1 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicinal Products (GTMP) Revenue in 2020
3.5 Gene Therapy Medicinal Products (GTMP) Key Players Head office and Area Served
3.6 Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
3.7 Date of Enter into Gene Therapy Medicinal Products (GTMP) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2022-2027)

5 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
6.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type
6.2.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application
6.3.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
6.4 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country
6.4.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type
7.2.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application
7.3.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
7.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country
7.4.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
9.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type
9.2.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application
9.3.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country
9.4.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.8.5 Advantagene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gene Therapy Medicinal Products (GTMP) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gene Therapy Medicinal Products (GTMP) Market Share by Regions (2016-2021)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gene Therapy Medicinal Products (GTMP) Market Share by Regions (2022-2027)
Table 10. Gene Therapy Medicinal Products (GTMP) Market Trends
Table 11. Gene Therapy Medicinal Products (GTMP) Market Drivers
Table 12. Gene Therapy Medicinal Products (GTMP) Market Challenges
Table 13. Gene Therapy Medicinal Products (GTMP) Market Restraints
Table 14. Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players (2016-2021)
Table 16. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2020)
Table 17. Ranking of Global Top Gene Therapy Medicinal Products (GTMP) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
Table 21. Date of Enter into Gene Therapy Medicinal Products (GTMP) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2016-2021)
Table 25. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gene Therapy Medicinal Products (GTMP) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2016-2021)
Table 29. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bluebird Bio Company Details
Table 62. Bluebird Bio Business Overview
Table 63. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product
Table 64. Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 65. Bluebird Bio Recent Development
Table 66. Sangamo Company Details
Table 67. Sangamo Business Overview
Table 68. Sangamo Gene Therapy Medicinal Products (GTMP) Product
Table 69. Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 70. Sangamo Recent Development
Table 71. Spark Therapeutics Company Details
Table 72. Spark Therapeutics Business Overview
Table 73. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 74. Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 75. Spark Therapeutics Recent Development
Table 76. Dimension Therapeutics Company Details
Table 77. Dimension Therapeutics Business Overview
Table 78. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 79. Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 80. Dimension Therapeutics Recent Development
Table 81. Avalanche Bio Company Details
Table 82. Avalanche Bio Business Overview
Table 83. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product
Table 84. Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 85. Avalanche Bio Recent Development
Table 86. Celladon Company Details
Table 87. Celladon Business Overview
Table 88. Celladon Gene Therapy Medicinal Products (GTMP) Product
Table 89. Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 90. Celladon Recent Development
Table 91. Vical Inc. Company Details
Table 92. Vical Inc. Business Overview
Table 93. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product
Table 94. Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 95. Vical Inc. Recent Development
Table 96. Advantagene Company Details
Table 97. Advantagene Business Overview
Table 98. Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021) & (US$ Million)
Table 99. Advantagene Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Monogenic Case Studies
Figure 7. Infectious Disease Case Studies
Figure 8. Cardiovascular Disease Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy Medicinal Products (GTMP) Report Years Considered
Figure 11. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gene Therapy Medicinal Products (GTMP) Market Share by Regions: 2020 VS 2027
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market Share by Regions (2022-2027)
Figure 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players in 2020
Figure 16. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue in 2020
Figure 18. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2016-2021)
Figure 19. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2022-2027)
Figure 20. North America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2016-2027)
Figure 22. North America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2016-2027)
Figure 23. North America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2016-2027)
Figure 24. United States Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Type (2016-2027)
Figure 28. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Application (2016-2027)
Figure 29. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Country (2016-2027)
Figure 30. Germany Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2016-2027)
Figure 40. China Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2016-2027)
Figure 48. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2016-2027)
Figure 49. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2016-2027)
Figure 50. Mexico Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Country (2016-2027)
Figure 56. Turkey Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 60. Sangamo Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 61. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 62. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 63. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 64. Celladon Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 65. Vical Inc. Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 66. Advantagene Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年）

Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4246 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遺伝子検出用個別化癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査）、用途別市場規模（病院、クリニック、診断センタ...

世界の強度変調陽子線治療（IMPT）市場規模・現状・予測（2021年-2027年）

Global Intensity-Modulated Proton Therapy (IMPT) Market Size, Status and Forecast 2021-2027
QFJ1-5215 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、強度変調陽子線治療（IMPT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シンクロトロン型、サイクロトロン型、同期サイクロトロン型、線形加速器型）、用途別市場規模（病院、陽子線治療センター、その他...

世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Tools and Reagents Market Size, Status and Forecast 2021-2027
QFJ1-5121 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、細胞・遺伝子治療用ツール＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学発光免疫測定法（CLIA）、フルオロイムノアッセイ、マルチプレックスアッセイ、迅速診断技術）、用途別市場規模（病院、研...

世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5749 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、遺伝子治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経筋疾患、遺伝病、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のゴーシェ病＆ポンペ病酵素補充療法（ERT）市場規模・現状・予測（2021年-2027年）

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Status and Forecast 2021-2027
QFJ1-4244 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法（ERT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ポンペ病）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の消費者用遺伝子検査（DTC）市場規模・現状・予測（2021年-2027年）

Global Genetic Testing for Consumers (DTC) Market Size, Status and Forecast 2021-2027
QFJ1-4253 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、消費者用遺伝子検査（DTC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キャリア検査、予測検査、祖先＆関係検査、ニュートリゲノミクス検査、その他）、用途別市場規模（オンラインプラットフォーム、店頭...

世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3985 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO...

世界のウイルスベクター＆非ウイルスベクター製造＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, Status and Forecast 2021-2027
QFJ1-5027 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AAV、アデノウイルス、レンチウイルス、レトロウイルス、プラスミドDNA、その他ベクター）、用途別市...

世界の着床前診断（PGD）市場規模・現状・予測（2021年-2027年）

Global Preimplantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2021-2027
QFJ1-4750 2021年6月 122Pages
QYResearch社発行の本調査レポートでは、着床前診断（PGD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（染色体異常、性別選択、X連鎖性疾患、異数性、単一遺伝子障害、その他）、用途別市場規模（マタニティセンター＆不妊治療クリニック、病院、...

世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027
QFJ1-6028 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（...

世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年） A method to provide patients with individualized treatment of cancer tumors Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX m…
世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Drugs Market The global Gene Therapy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…
世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell and Gene Therapy Tools and Reagents Market The global Cell and Gene Therapy Tools and Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年） Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two typ…
世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting …